Investors Seem Unshaken by Study of the Merck Drug Zetia - NYTimes.com
Links shared publicly online about this topic.
- 1,597total visits
Investors Seem Unshaken by Study of the Merck Drug Zetia - NYTimes.com
The results of the long-awaited trial could have been worse for Zetia, the blockbuster cholesterol-lowering drug, analysts said, and the drug maker’s shares rose.
View full resource at nytimes.com
Tags: Cholesterol Medication, Drug, Zetia, Merck & Co.
Most Recently Shared on November 17, 2009 at 3:26 am By:
Investors Seem Unshaken After Study of Merck Drug - New York Times http://ow.ly/162ccj
Advertisement
